Literature DB >> 22862890

Towards a clinical staging for bipolar disorder: defining patient subtypes based on functional outcome.

María Reinares1, Efstathios Papachristou, Philip Harvey, C Mar Bonnín, José Sánchez-Moreno, Carla Torrent, José L Ayuso-Mateos, George B Ploubidis, Eduard Vieta, Sophia Frangou.   

Abstract

BACKGROUND: The functional outcome of Bipolar Disorder (BD) is highly variable. This variability has been attributed to multiple demographic, clinical and cognitive factors. The critical next step is to identify combinations of predictors that can be used to specify prognostic subtypes, thus providing a basis for a staging classification in BD.
METHODS: Latent Class Analysis was applied to multiple predictors of functional outcome in a sample of 106 remitted adults with BD.
RESULTS: We identified two subtypes of patients presenting "good" (n=50; 47.6%) and "poor" (n=56; 52.4%) outcome. Episode density, level of residual depressive symptoms, estimated verbal intelligence and inhibitory control emerged as the most significant predictors of subtype membership at the p<0.05 level. Their odds ratio (OR) and confidence interval (CI) with reference to the "good" outcome group were: episode density (OR=4.622, CI 1.592-13.418), level of residual depressive symptoms (OR=1.543, CI 1.210-1.969), estimated verbal intelligence (OR=0.969; CI 0.945-0.995), and inhibitory control (OR=0.771, CI 0.656-0.907). Age, age of onset and duration of illness were comparable between prognostic groups. LIMITATIONS: The longitudinal stability or evolution of the subtypes was not tested.
CONCLUSIONS: Our findings provide the first empirically derived staging classification of BD based on two underlying dimensions, one for illness severity and another for cognitive function. This approach can be further developed by expanding the dimensions included and testing the reproducibility and prospective prognostic value of the emerging classes. Developing a disease staging system for BD will allow individualised treatment planning for patients and selection of more homogeneous patient groups for research purposes.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22862890     DOI: 10.1016/j.jad.2012.06.005

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  21 in total

1.  TSPO upregulation in bipolar disorder and concomitant downregulation of mitophagic proteins and NLRP3 inflammasome activation.

Authors:  Giselli Scaini; Tatiana Barichello; Gabriel R Fries; Elizabeth A Kennon; Taylor Andrews; Bobby R Nix; Giovana Zunta-Soares; Samira S Valvassori; Jair C Soares; João Quevedo
Journal:  Neuropsychopharmacology       Date:  2018-12-11       Impact factor: 7.853

2.  Changes in the corpus callosum in women with late-stage bipolar disorder.

Authors:  L Lavagnino; B Cao; B Mwangi; M-J Wu; M Sanches; G B Zunta-Soares; F Kapczinski; J Soares
Journal:  Acta Psychiatr Scand       Date:  2015-01-31       Impact factor: 6.392

Review 3.  Staging and neuroprogression in bipolar disorder.

Authors:  Gabriel Rodrigo Fries; Bianca Pfaffenseller; Laura Stertz; André Vinicius Contri Paz; Aroldo Ayub Dargél; Maurício Kunz; Flávio Kapczinski
Journal:  Curr Psychiatry Rep       Date:  2012-12       Impact factor: 5.285

Review 4.  Treatment of Functional Impairment in Patients with Bipolar Disorder.

Authors:  Jose Sanchez-Moreno; Anabel Martinez-Aran; Eduard Vieta
Journal:  Curr Psychiatry Rep       Date:  2017-01       Impact factor: 5.285

Review 5.  Early interventions for youths at high risk for bipolar disorder: a developmental approach.

Authors:  Xavier Benarous; Angèle Consoli; Vanessa Milhiet; David Cohen
Journal:  Eur Child Adolesc Psychiatry       Date:  2015-09-22       Impact factor: 4.785

6.  Staging in bipolar disorder: from theoretical framework to clinical utility.

Authors:  Michael Berk; Robert Post; Aswin Ratheesh; Emma Gliddon; Ajeet Singh; Eduard Vieta; Andre F Carvalho; Melanie M Ashton; Lesley Berk; Susan M Cotton; Patrick D McGorry; Brisa S Fernandes; Lakshmi N Yatham; Seetal Dodd
Journal:  World Psychiatry       Date:  2017-10       Impact factor: 49.548

7.  Modifiable and non-modifiable factors associated with functional impairment during the inter-episodic periods of bipolar disorder.

Authors:  Andrea Murru; Isabella Pacchiarotti; Norma Verdolini; Maria Reinares; Carla Torrent; Pierre-Alexis Geoffroy; Frank Bellivier; Pierre-Michel Llorca; Eduard Vieta; Ludovic Samalin
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-05-22       Impact factor: 5.270

8.  Inflammation as a Mechanism of Bipolar Disorder Neuroprogression.

Authors:  Tatiana Barichello; Vijayasree Vayalanellore Giridharan; Gursimrat Bhatti; Pavani Sayana; Tejaswini Doifode; Danielle Macedo; Joao Quevedo
Journal:  Curr Top Behav Neurosci       Date:  2021

9.  The impact of repeated manic episodes and executive dysfunction on work adjustment in bipolar disorder.

Authors:  C M Bonnín; C Torrent; J M Goikolea; M Reinares; B Solé; M Valentí; J Sánchez-Moreno; D Hidalgo; R Tabarés-Seisdedos; A Martínez-Arán; E Vieta
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-08-03       Impact factor: 5.270

10.  Depressive residual symptoms are associated with illness course characteristics in a sample of outpatients with bipolar disorder.

Authors:  Gianluca Serafini; Gustavo H Vazquez; Xenia Gonda; Maurizio Pompili; Zoltan Rihmer; Mario Amore
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-02-07       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.